REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Changes in Contract Assets and Contract Liabilities

The following table summarized the changes in the contract asset and liability balances for the year ended December 31, 2022:

Dollars in thousands	Total
Contract Asset
Contract asset, January 1, 2022	$	11,412
Transferred to trade receivable from contract asset included      in beginning of the year contract asset	(11,412)
Contract asset, net of transferred to trade receivables on contracts during the period	10,122
Contract asset, December 31, 2022	$	10,122
Contract Liability
Contract liability, January 1, 2022	$	11,946
Recognition of revenue included in beginning of year contract liability	(5,349)
Contract liability, net of revenue recognized on contracts during the period	9,596
Foreign currency translation	(66)
Contract liability, December 31, 2022	$	16,127

Schedule of Disaggregation of Revenue

The following table presents revenues disaggregated by the major sources of revenues for years-ended December 31, 2022, 2021 and 2020 (dollar amounts in thousands):

	Year Ended December 31, 2022		Year Ended December 31, 2021		Year Ended December 31, 2020
Neurosurgery	$	794,017	$	802,959	$	716,339
Instruments	225,547		222,273		178,492
Total Codman Specialty Surgical	1,019,564		1,025,232		894,831
Wound Reconstruction and Care(2)(3)	406,689		392,463		293,038
Extremity Orthopedics(1)	—		—		78,316
Private Label	131,413		124,753		105,683
Total Tissue Technologies	538,102		517,216		477,037
Total revenue	$	1,557,666	$	1,542,448	$	1,371,868

(1) On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, Acquisitions and Divestitures, for details

(2) See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.

(3) On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note 4, Acquisitions and Divestitures